Hledání článků
Filtry
Hofstra JM, Willems JL, Wetzels JFM. Estimated glomerular filtration rate in the nephrotic syndrome. Nephrol Dial Transpl 2011;26:550–556.
Rognant N, Bacchetta J, Dubourg L, et al. What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis? Nephrol Dial Transpl 2010;25:3569–3575.
Eyler RF, Mueller BA. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol 2011;7:226–235.
Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T, for SWEDEHEART. Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney Int 2011;79:997–1004.
Farese S, Stauffer E, Kalicki R, et al. Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol 2011; 6:1447–1455.
Geetha D, Eirin A, True K, et al. Renal transplantation in antineutrophil cytoplasmic antibody‑associated vasculitis: A multicenter experience. Transplantation 2011;91:1370–1375.
La Manna G, Pizza F, Persici E, Baraldi O, Comai G, Cappuccilli ML, Centofanti F, Carretta E, Plazzi G, Colí L, Montagna P, Stefoni S. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end‑stage kidney disease undergoing long‑term haemodialysis treatment. Nephrol Dial Transplant 2011;26:1976–1983.
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD; for the National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Network. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011, v tisku.
Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison. Crit Care Med 2011, v tisku
Clement LC, Avila‑Casado C, Macé C, et al. Podocyte‑secreted angiopoietin‑like‑4 mediates proteinurie in glucocorticoid‑sensitive nephrotic syndrome. Nat Med 2011;17:117–122.
Stanescu HC, Arcos‑Burgos M, Medlar A, et al. Risk HLA‑DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011;364:616–626.
Navarra SV, Guzmán RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo‑controlled, phase 3 trial. Lancet 2011;377:721–731.